This may suggest that angiogenic circuitry in GBM may include different complementary inputs from GSCs and their differentiated progeny, each contributing different amounts of either VEGF (growth factor)-dependent or EV-dependent activities, the latter of which were never therapeutically addressed [44]. Here, VEGFA is linked to glioblastoma.